The Little Canada-based company develops medical technology, products and services that treat cardiac, neurological and chronic pain patients.
Delayed Price / Updated: /
|52 Week High||60.78|
|52 Week Low||35.32|
|Today's Range||61.79 - 60.83|
St. Jude Medical on Thursday announced it has received European CE Mark approval for its 25 mm Portico Transcatheter Aortic Heart Valve Implantation System. The Little Canada-based company said the...
For people with chronic pain, the growth of neurostimulation — use of an electric current to block pain messages from reaching the brain — has been a welcome relief. But the technology...
Medtronic Inc. announced Thursday that the U.S. Food and Drug Administration has approved broader use of its lead alert software that will ultimately ensure that a variety of leads, not just its own,...
And the winning streak continues for St. Jude Medical.The Little Canada-based company reported strong quarterly sales and earnings in what analysts are calling an especially solid year for the...
St. Jude Medical Inc. on Monday announced the acquisition of Nanostim Inc., giving the Little Canada-based medical technology company the world’s first commercially available “leadless”...
|Current year rank||34|
|Current year compensation||$2,934,295|
|Percent change of the CEO||-5.1|
The Little Canada-based company is beginning to enroll U.S. patients in a clinical study of its new spinal cord stimulation system, which delivers what it calls burst stimulation.
Minnesota Topics are a comprehensive collection of Star Tribune content on select people, places and companies.